We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West is pleased to announce the official opening of its new Waterford, Ireland facility, a global center of excellence for West’s advanced manufacturing network. The opening was celebrated on July 19, 2018, when customers and senior-level Irish government officials joined West executives at a ribbon-cutting ceremony.
Noted West President and CEO Eric Green in a recent press release, “West is very pleased to celebrate the official opening of our state-of-the-art facility in Waterford…Our investment in Waterford, in addition to our previously announced investments in Kinston, N.C., Jurong, Singapore, and Dublin, Ireland, enable West to provide the highest levels of quality across the products and services we provide for the global customer base we serve.”
The new, 20,500 square meter facility is situated on a 44-acre campus, and will produce West’s proprietary elastomeric laminate sheeting, used to package insulin for use in pen injectors. Additionally, it will offer high-value finishing for components, including stoppers and plungers, produced at other West facilities around the world. These services, designed to mitigate the risk of potential contamination and compatibility issues with packaging components, include pharmaceutical washing (Westar® RS components), Envision® verification, steam sterilization (Westar® RU components), and flexible packaging offerings.
West’s Waterford facility currently employs approximately 100 people in both local and global functions, with plans for additional hiring. Commercial production in Waterford is expected this year. West also has a manufacturing and development center in Dublin that provides design, development and manufacturing services for pharmaceutical and medical technology customers. The Dublin site recently completed an expansion to accommodate new customer programs and employs approximately 600 people.
For more information on West and current job openings in the region, please visit the careers section of our website.
Quality. Technology. Trends in manufacturing. Injection systems. Primary containers. Global market trends. What does each of these areas have in common? Over the past decade tremendous progress has been made in drug delivery, but challenges continue.
Traditionally, drugs and biologics have been sold in vials. Utilizing a vial system requires the use of a syringe or other transfer device to withdraw the medication from the vial and facilitate delivery directly to the patient or to an IV bag for subsequent administration to the patient. These steps can result in errors, spills, contamination, or other mishaps. A simplified approach for administration has been to package the drug or biologic as a <a href="/blog/2022/january/importance-of-prefilled-syringe-packaging-in-market">pre-filled syringe</a> combination product. Drug administration is then made easier because the syringe is both the containment system and the delivery system such that the drug can be directly injected into a patient or into an IV bag port.
As we celebrate our 240<sup>th</sup> Independence Day, we would like to take a moment to express our appreciation to veterans and their families who serve to help keep America safe and to those who came before them in this noble cause.
From May 13 to June 4, team members at our Exton, PA site banded together in our annual West without Borders (WWB) Giving Campaign in the hopes of making a big difference for Fox Chase Cancer Center and Suicide Awareness Voices of Education (SAVE).
West Regulatory Affairs (RA) has a goal of harmonizing site-specific Drug Master Files (DMFs) into a global document as the processes at different facilities are synchronized.
English
Chinese
